Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first outbreak of cVDPV was identified in the Dominican Republic and Haiti between 2000 and 2001.”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“In general, the VP1 sequences examined from cVDPV isolates differed from parental OPV strains by only 1–3.5%, suggesting that reversion to the attenuated phenotype of Sabin strains occurs with circulation times of 1–4 years [91,92,93,95,100].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“As with the other epidemics in Egypt and Hispaniola, VDPV circulated in a province of Madagascar with low OPV coverage (6,7).”
From Recombinant Vaccine–Derived Poliovirus in Madagascar (2003) · cites this paper as [7]
In the citing paper
“Most VDPV strains described as OPV/HEV-C recombinants were isolated in countries in which wild PVs have been eradicated”
From Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar (2007) · cites this paper as [12]
In the citing paper
“The cVDPV had recovered two of the most important biological properties of wild PV: the capacity to cause severe paralytic disease in humans and the capacity for extensive human-to-human transmission.”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [83]
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oberste, M. S., Maher, K., Kilpatrick, D. R., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1941-1948.1999 · Cited by 866
Self-citationStrebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Self-citationKawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232
NATHANSON, N., & MARTIN, J. R. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112848 · Cited by 214
Antigenic Structure of Picornaviruses
Minor, P. D. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75602-3_5 · Cited by 187
Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.958-964.1999 · Cited by 160
Molecular epidemiology of polioviruses
Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157
Self-citationDeterminants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140
Comparative study of five methods for intratypic differentiation of polioviruses
van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122
Self-citationMinor, P. D., & Dunn, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-5-1091 · Cited by 120
Research works printed but not linked: 5
- Andrus J. K., Strebel P. M., de Quadros C. A., Olive J. M., Bull. WHO 73, 33 (1995).
- Supplementary figures and details of experimental procedures are available on Science Online at www.sciencemag.org/cgi/content/full/1068284/DC1.
- Minor P. D., Curr. Top. Microbiol. Immunol. 161, 121 (1990).
- ___, Morb. Mortal. Wkly. Rep. 50, 41 (2001).
- Wood D. J., Sutter R. W., Dowdle W. R., Bull. WHO 78, 347 (2000).
Cited by
Microbial contamination of drinking water and disease outcomes in developing regions
Ashbolt, N. J. (2004) · Toxicology · doi:10.1016/j.tox.2004.01.030 · Cited by 1,080
Virus attenuation by genome-scale changes in codon pair bias
Coleman, J. R., Papamichail, D., Skiena, S., Futcher, B., Wimmer, E., & Mueller, S. (2008) · Science · doi:10.1126/science.1155761 · Cited by 715
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Self-citationLive attenuated vaccines: Historical successes and current challenges
Minor, P. D. (2015) · Virology · doi:10.1016/j.virol.2015.03.032 · Cited by 495
Virulence and competitive ability in genetically diverse malaria infections
de Roode, J. C., Pansini, R., Cheesman, S. J., Helinski, M. E. H., Huijben, S., Wargo, A. R., Bell, A. S., Chan, B. H. K., Walliker, D., & Read, A. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500078102 · Cited by 422
From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed
Nathanson, N., & Kew, O. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq320 · Cited by 404
“Second, the gradual establishment of an extraordinary global network for the isolation and characterization of polioviruses (102) during the period 1990–2000 facilitated reconstruction of the molecular epidemiology of such outbreaks (97, 98).”
BackgroundSelf-citationAndino, R., & Domingo, E. (2015) · Virology · doi:10.1016/j.virol.2015.03.022 · Cited by 368
“, 2003) in vaccinated individuals (Arita et al., 2005; Jegouic et al., 2009; Jiang et al., 2007; Kew et al., 2002; Shimizu et al., 2004).”
BackgroundRole of environmental poliovirus surveillance in global polio eradication and beyond
HOVI, T., SHULMAN, L. M., VAN DER AVOORT, H., DESHPANDE, J., ROIVAINEN, M., & DE GOURVILLE, E. M. (2012) · Epidemiology and Infection · doi:10.1017/s095026881000316x · Cited by 318
“Recent circulating VDPV (cVDPV) outbreaks have, however, raised concern that, under certain circumstances, especially following decreased OPV coverage [28], the OPV strains have the potential to cause sustained transmission and paralytic disease [29–39].”
BackgroundRobinson, C. M., Jesudhasan, P. R., & Pfeiffer, J. K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2013.12.004 · Cited by 317
“Interestingly, many fecal/sewage isolates from the K99-containing Sabin serotype 1 vaccine have T, N, R, E, S, or G at position 99, suggesting that lysine at this position may confer a selective disadvantage (Kew et al., 1998, 2002; van der Sanden et al., 2009; Yakovenko et al., 2006).”
Burns, C. C., Diop, O. M., Sutter, R. W., & Kew, O. M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu295 · Cited by 309
“1% of reported cases) were associated with the outbreaks in Hispaniola in 2000–2001 and Indonesia in 2005 [8, 37].”
BackgroundSelf-citationPublic Health Surveillance: A Tool for Targeting and Monitoring Interventions
Nsubuga, P., White, M., Thacker, S. B., Anderson, M., Blount, S. B., Broome, C. V., Chiller, T. M., Espitia, V. E., Imtiaz, R., Sosin, D., et al. (2006) · Cited by 439
Bell, A. S., Roode, J. C., Sim, D., & Read, A. F. (2006) · Evolution · doi:10.1111/j.0014-3820.2006.tb01215.x · Cited by 267
Imbroglios of Viral Taxonomy: Genetic Exchange and Failings of Phenetic Approaches
Lawrence, J. G., Hatfull, G. F., & Hendrix, R. W. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.17.4891-4905.2002 · Cited by 268
Dynamics of Multiple Infection and Within‐Host Competition in Genetically Diverse Malaria Infections
de Roode, J. C., Helinski, M. E. H., Anwar, M. A., & Read, A. F. (2005) · The American Naturalist · doi:10.1086/491659 · Cited by 261
“The same is true for vaccine-escape mutants (e.g., Kew et al. 2002): their evolution and spread through the population will depend on their competitiveness with attenuated pathogen forms in vaccinated hosts and wild-type strains in others (Bull 1994).”
BackgroundOberste, M. S., Maher, K., & Pallansch, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.855-867.2004 · Cited by 260
Self-citationBurns, C. C., Shaw, J., Campagnoli, R., Jorba, J., Vincent, A., Quay, J., & Kew, O. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3259-3272.2006 · Cited by 259
“The mono-, di-, and trinucleotide frequency patterns are similar for the three Sabin strains (70) and appear to be conserved across poliovirus genotypes (24, 35, 39, 42, 46, 78) and other human enterovirus species C serotypes (8).”
BackgroundSelf-citationCirculating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · PubMed · doi:10.1590/s0042-96862004000100006 · Cited by 258
“Like wild polioviruses, cVDPV isolates have been shown to replicate to high titres in cell culture at supraoptimal temperatures ( 24, 29 ).”
InfluentialSelf-citationHost and virus determinants of picornavirus pathogenesis and tropism
Whitton, J. L., Cornell, C. T., & Feuer, R. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1284 · Cited by 252
“To complicate matters further, it seems that the above two sources can combine; in 2000–2001, an outbreak of paralytic poliomyelitis occurred in Hispaniola and was traced to a vaccine-derived virus that had recombined with a wild enteroviru”
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
“Moreover, the outbreaks in Egypt and Madagascar were associated with type 2 cVDPV, whereas the outbreaks in Hispaniola and the Philippines were associated with type 1 cVDPV. Genetic evidence suggests that cVDPV spread along multiple independent chains of transmission in both Egypt and Haiti (22).”
BackgroundInfluentialSelf-citationGraham, R. L., Becker, M. M., Eckerle, L. D., Bolles, M., Denison, M. R., & Baric, R. S. (2012) · Nature Medicine · doi:10.1038/nm.2972 · Cited by 230
Specific Capture and Whole-Genome Sequencing of Viruses from Clinical Samples
Depledge, D. P., Palser, A. L., Watson, S. J., Lai, I. Y.-C., Gray, E. R., Grant, P., Kanda, R. K., Leproust, E., Kellam, P., & Breuer, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027805 · Cited by 229
“Genetic variation defines virus population structures and is used effectively in determining transmission chains [2].”
BackgroundEnteroviruses as agents of emerging infectious diseases
Palacios, G., & Oberste, M. (2005) · Journal of Neurovirology · doi:10.1080/13550280591002531 · Cited by 223
“EV71 has caused epidemics of severe neurologic disease in Australia, Europe, Asia, and the United States (Abubakar et al, 1998; Alexander et al, 1994; Blomberg et al, 1974; Chonmaitree et al, 1981; Chumakov et al, 1979; da Silva et al, 1996; Deibel et al, 1977; Gilbert et al, 1988; Ishimaru et al, 1980; Kennett et al,…”
BackgroundSelf-citationEngineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Kündig, T. M., Senti, G., Schnetzler, G., Wolf, C., Prinz Vavricka, B. M., Fulurija, A., Hennecke, F., Sladko, K., Jennings, G. T., & Bachmann, M. F. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.040 · Cited by 199
Kilpatrick, D. R., Yang, C.-F., Ching, K., Vincent, A., Iber, J., Campagnoli, R., Mandelbaum, M., De, L., Yang, S.-J., Nix, A., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00702-09 · Cited by 187
“2008) wild poliovirus genotypes (5, 6, 18) spanning the widest”
BackgroundSelf-citationVaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication
Minor, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.071 · Cited by 183
Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
“Direct C3G transversions appear to be rare in poliovirus (39, 46, 52, 75, 89, 90) and other picornaviruses (24), and most C3G substitutions in poliovirus probably occur via two steps, C3A3G, as inferred several times for the Andean lineages.”
BackgroundSelf-citationRisks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication
Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H., Cochi, S. L., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00827.x · Cited by 174
Self-citationBurns, C. C., Campagnoli, R., Shaw, J., Vincent, A., Jorba, J., & Kew, O. (2009) · Journal of Virology · doi:10.1128/jvi.00508-09 · Cited by 170
“recombination during circulation of poliovirus in human populations (20, 30, 32).”
BackgroundSelf-citationSutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Self-citationGenetic variability of hepatitis A virus
Costa-Mattioli, M., Napoli, A. D., Ferré, V., Billaudel, S., Perez-Bercoff, R., & Cristina, J. (2003) · Journal of General Virology · doi:10.1099/vir.0.19532-0 · Cited by 164
“Evidence of recombination in polio- and enteroviruses was confined to areas far removed from the capsid region (Kew & Nottay, 1984; Lipskaya et al., 1991; Guillot et al., 2000; Cuervo et al., 2001; Kew et al., 2002).”
Emerging Viral Infections of the Central Nervous System: Part 1
Tyler, K. L. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.153 · Cited by 158
“Thefirstpoliooutbreakattributedtocirculatingvaccinederived poliovirus occurred in 2000 in Hispaniola.7 SubsequentoutbreaksoccurredinthePhilippines,Indonesia,Cambodia, China, Egypt, and Madagascar.8,9 Even though the useoforalpoliovaccineended in theUnitedStates in2000, a small outbreak of polio infection resulting fro…”
BackgroundTransgenic mouse model for the study of enterovirus 71 neuropathogenesis
Fujii, K., Nagata, N., Sato, Y., Ong, K. C., Wong, K. T., Yamayoshi, S., Shimanuki, M., Shitara, H., Taya, C., & Koike, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217563110 · Cited by 158
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Self-citationCirculation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
“Haiti in Hispaniola (25) and the subsequent outbreak in Mada-”
BackgroundMethodResultInfluentialSelf-citationFlingai, S., Czerwonko, M., Goodman, J., Kudchodkar, S. B., Muthumani, K., & Weiner, D. B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00354 · Cited by 147
Polio eradication: the OPV paradox
Dowdle, W. R., De Gourville, E., Kew, O. M., Pallansch, M. A., & Wood, D. J. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.401 · Cited by 144
“Widening the sequencing window to the complete poliovirus genome increases the ability to discriminate among closely related viruses [39].”
BackgroundInfluentialSelf-citationMacklin, G. R., O’Reilly, K. M., Grassly, N. C., Edmunds, W. J., Mach, O., Santhana Gopala Krishnan, R., Voorman, A., Vertefeuille, J. F., Abdelwahab, J., Gumede, N., et al. (2020) · Science · doi:10.1126/science.aba1238 · Cited by 141
Self-citationRecombinant Vaccine–Derived Poliovirus in Madagascar
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P., & Delpeyroux, F. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020692 · Cited by 138
“Emerging Infectious Diseases, 2003, 9 (7), pp.”
RNA Recombination Plays a Major Role in Genomic Change during Circulation of Coxsackie B Viruses
Oberste, M. S., Peñaranda, S., & Pallansch, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2948-2955.2004 · Cited by 137
Self-citationEvidence of intratypic recombination in natural populations of hepatitis C virus
Colina, R., Casañe, D., Vásquez, S., García, L., Chunga, A., Romero, H., Khan, B., & Cristina, J. (2004) · Journal of General Virology · doi:10.1099/vir.0.19472-0 · Cited by 155
“…breakpoint for non-segmented positive-strand RNA viruses, such as polioviruses and other picornaviruses (Santti et al., 1999; Guillot et al., 2000; Kew et al., 2002), as well as members of the family Flaviviridae, are often located in the part of the genome encoding the non-structural proteins…”
BackgroundCombelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
“Nevertheless, recombination in the PV capsid proteins VP1 and VP2 has been sometimes found [42–48].”
BackgroundInfluentialLorin, C., Mollet, L., Delebecque, F., Combredet, C., Hurtrel, B., Charneau, P., Brahic, M., & Tangy, F. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.146-157.2004 · Cited by 136
“However, poliovirus is less genetically stable than MV, and reversion to pathogenicity may occur (35).”
BackgroundRecombination in Enteroviruses, a Multi-Step Modular Evolutionary Process
Muslin, C., Kain, A. M., Bessaud, M., Blondel, B., & Delpeyroux, F. (2019) · Viruses · doi:10.3390/v11090859 · Cited by 142
“Data are modified from [73] (Egypt), [67] (Greece), [68] (Hispaniola), [69] (Philippines), [71,72] (Nigeria), [65,66,70,76] (Madagascar), [120] (Cambodia).”
Choisy, M., & de Roode, J. C. (2010) · The American Naturalist · doi:10.1086/651587 · Cited by 126
“DOI: 10.1086/651587 cess of parasites, these interactions have important consequences for the epidemiology and evolution of traits such as resistance to drugs and vaccines (Hastings and D’Alessandro 2000; Kew et al. 2002; Wargo et al. 2007).”
BackgroundInfluentialPreclinical and Clinical Safety Studies on DNA Vaccines
Schalk, J. A. C., Mooi, F. R., Berbers, G. A. M., Aerts, L. A. G. J. M. V., Ovelgönne, H., & Kimman, T. G. (2006) · Human Vaccines · doi:10.4161/hv.2.2.2620 · Cited by 127
“Possible environmental risks of DNA vaccines that can be anticipated are: (1) environmental spread of recombinant plasmid vectors by shedding or by consumption of vaccinated animals, (2) recombination with viruses, bacteria, or parasites inside the vaccinated host, and consequently the generation and spread of genetic…”
BackgroundWassilak, S., Pate, M. A., Wannemuehler, K., Jenks, J., Burns, C., Chenoweth, P., Abanida, E. A., Adu, F., Baba, M., Gasasira, A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq140 · Cited by 120
Self-citationJegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
“poliovaccine enteroviruses — either wild PVs or non-PV HEV-C [3,6-13].”
BackgroundTapiainen, T., Prevots, D. R., Izurieta, H. S., Abramson, J. S., Bilynsky, R., Bonhoeffer, J., Bonnet, M.-C., Galama, J. M. D., Gillard, P. H., Griot, M., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.058 · Cited by 122
“The most comprehensive experience in this regard is that gathered for polioviruses [64–67].”
Khetsuriani, N., Prevots, D. R., Quick, L., Elder, M. E., Pallansch, M., Kew, O., & Sutter, R. W. (2003) · The Journal of Infectious Diseases · doi:10.1086/379791 · Cited by 110
Self-citationMucosal vaccines: novel advances in technology and delivery
Yuki, Y., & Kiyono, H. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.61 · Cited by 119
Vaccines, Vaccination, and Vaccinology
Plotkin, S. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/374419 · Cited by 116
“end of a reverted poliovirus combines with the 3′ end of another enterovirus, the result is a virus that not only is neurovirulent but also can be transmitted easily and become epidemic [15].”
BackgroundHigh Frequency and Diversity of Species C Enteroviruses in Cameroon and Neighboring Countries
Sadeuh-Mba, S. A., Bessaud, M., Massenet, D., Joffret, M.-L., Endegue, M.-C., Njouom, R., Reynes, J.-M., Rousset, D., & Delpeyroux, F. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02119-12 · Cited by 108
“With few exceptions (11), all analyzed cVDPVs were shown to be recombinant strains having capsid coding regions derived from OPV-related PVs and certain or all nonstructural regions of the genome originating from other HEV-C strains (3, 4, 12, 13).”
BackgroundBlackmore, T., Buchan, G. S., Grant, C. C., Grimwood, K., LENNON, D. R., Murdoch, D. R., Pierce, J., Reid, S., & Roberts, A. (2006) · Cited by 109
Iturriza‐Gómara, M., Megson, B., & Gray, J. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20533 · Cited by 109
“Additionally, there is evidence from recent outbreaks in Hispaniola (2000–2001), the Philippines (2001), and Madagascar (2001–2002) of reversion of Sabin poliovirus vaccine strains to neurovirulence [Kew et al., 2002, 2004].”
BackgroundYoke-Fun, C., & AbuBakar, S. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-74 · Cited by 113
“The incongruent phylogeny patterns observed suggest the possible occurrence of recombination in EV-71 in a similar manner to those previously reported for a number of enteroviruses [21-27].”
ResultHalsey, N. A., Pinto, J. A., Espinosa-Rosales, F. J., Faure-Fontenla, M. A., da Silva, E., Khan, A. J., WEBSTER, A. D. B., Minor, P. D., Dunn, G., Asturias, E. J., et al. (2004) · Europe PMC (PubMed Central) · Cited by 106
Self-citationJiang, P., Faase, J. A. J., Toyoda, H., Paul, A., Wimmer, E., & Gorbalenya, A. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700451104 · Cited by 105
Dunn, G., Klapsa, D., Wilton, T., Stone, L., Minor, P. D., & Martin, J. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005114 · Cited by 106
“6% for serotype 2 poliovirus) sequence drift in the capsid VP1 gene with respect to the corresponding Sabin strain, can be generated and transmitted from person to person in populations with low immunity and have been associated with a number of poliomyelitis outbreaks around the world [5–9].”
BackgroundBlomqvist, S., Savolainen, C., Laine, P., Hirttiö, P., Lamminsalo, E., Penttilä, E., Jöks, S., Roivainen, M., & Hovi, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4876-4883.2004 · Cited by 104
“A Sabin 3/Sabin 1 recombination is typical of most recipients of OPV, whereas the P3 region in discovered cVDPVs has been derived from an unidentified genetic group C virus (including the HEV-C and poliovirus species) (6, 8, 21, 41).”
BackgroundYang, C.-F., Chen, H.-Y., Jorba, J., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y.-C., Lin, T.-Y., Chen, P.-J., Shimizu, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12623-12634.2005 · Cited by 106
“Moreover, most of our phylogenetic comparisons are restricted to P1/capsid region sequences, which encode the defining biological properties of poliovirus (10, 34, 49, 89).”
BackgroundMethodResultInfluentialSelf-citationCherkasova, E., Laassri, M., Chizhikov, V., Korotkova, E., Dragunsky, E., Agol, V. I., & Chumakov, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633511100 · Cited by 101
Tebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 105
“(17–20) The first detected cVDPV outbreak occurred in 2000–2001 in Hispaniola,(15) and retrospective studies revealed a 1983–1993 cVDPV2 outbreak in Egypt,(21) a cVDPV3 outbreak in Poland in 1968 (associated with the experimental USOL-D-bac vaccine),(22,23) and possibly a cVDPV2 outbreak in Belarus between 1963 and 19…”
BackgroundInfluentialSelf-citationReemergence of recombinant vaccine–derived poliovirus outbreak in Madagascar.
Rakoto‐Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L., Venter, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587694 · Cited by 100
“cVDPV were reported in Haiti and the Dominican Republic, the Philippines, Madagascar, China, Cambodia, and Indonesia [8-12].”
BackgroundImmunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes
Mayer, R. L., Verbeke, R., Asselman, C., Aernout, I., Gul, A., Eggermont, D., Boucher, K. L., Théry, F., Maia, T. M., Demol, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33721-y · Cited by 112
Transmission of Imported Vaccine‐Derived Poliovirus in an Undervaccinated Community in Minnesota
Alexander, J. P., Ehresmann, K., Seward, J., Wax, G., Harriman, K., Fuller, S., Cebelinski, E. A., Chen, Q., Jorba, J., Kew, O. M., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/596052 · Cited by 99
“04) [16] and unlike the type 1 cVDPV isolates from Hispaniola [29] and the Philippines [30] (0.”
BackgroundResultInfluentialSelf-citationMechanisms and consequences of positive-strand RNA virus recombination
Bentley, K., & Evans, D. J. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001142 · Cited by 110
Lu, B., Huang, Y. P., Huang, L., Bao, L., Zheng, Z., Chen, Z., Chen, J., Hu, Q., & Wang, H. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03231.x · Cited by 97
“6 Virus-like particles (VLPs) represent a specific class of subunit vaccine that mimics the structure of authentic virus particles.”
BackgroundA Dynamic Model of Poliomyelitis Outbreaks: Learning from the Past to Help Inform the Future
Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Sutter, R. W., & Thompson, K. M. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi206 · Cited by 106
“We made the key assumption that vaccine-derived polioviruses with the capacity to cause outbreaks possess the same transmissibility and neurovirulence characteristics as wild polioviruses, consistent with laboratory studies (35, 40, 41).”
BackgroundResultSelf-citationCo-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar
Rakoto-Andrianarivelo, M., Guillot, S., Iber, J., Balanant, J., Blondel, B., Riquet, F., Martin, J., Kew, O., Randriamanalina, B., Razafinimpiasa, L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030191 · Cited by 96
“The first outbreak of poliomyelitis (21 cases) associated with VDPVs, was reported in 2000–2001, in the Dominican Republic and Haiti [12].”
BackgroundSelf-citationArita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95
“A recent report indicated that HEV-C was frequently isolated in Madagascar (around 50% of NEPV isolates), suggesting the possible involvement of HEV-C in the emergence of the recombinant cVDPVs (41).”
BackgroundInfluentialSelf-citationChapter 1 The Pathogenesis of Poliomyelitis: What We Don't Know
Nathanson, N. (2008) · Advances in Virus Research · doi:10.1016/s0065-3527(08)00001-8 · Cited by 95
Tebbens, R. J. D., Pallansch, M. A., Kalkowska, D. A., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12044 · Cited by 95
“(b) Outbreak curve showing laboratory-confirmed VDPV and polio-compatible cases,(96) and modeled paralytic incidence for Haiti.”
BackgroundResultInfluentialSelf-citationEradicating poliomyelitis: India's journey from hyperendemic to polio-free status.
John, T. J., & Vashishtha, V. M. (2013) · PubMed Central · Cited by 125
Blomqvist, S., Bruu, A.-L., Stenvik, M., & Hovi, T. (2003) · Journal of General Virology · doi:10.1099/vir.0.18708-0 · Cited by 94
“An outbreak of poliomyelitis on the island of Hispaniola was associated with circulating type 1 vaccine-derived poliovirus (Kew et al. , 2002).”
InfluentialRecombination among human non-polio enteroviruses: implications for epidemiology and evolution
Kyriakopoulou, Z., Pliaka, V., Amoutzias, G. D., & Markoulatos, P. (2014) · Virus Genes · doi:10.1007/s11262-014-1152-y · Cited by 96
Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa054960 · Cited by 90
Plant‐based oral vaccines against zoonotic and non‐zoonotic diseases
Shahid, N., & Daniell, H. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12604 · Cited by 100
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
“The first outbreak to be reported happened during 2000 and 2001 in Hispaniola, which had been certified free of polio in 1994 along with the rest of the countries in the Americas and which had a vaccination program of declining coverage, leading to the appearance of a vaccine-derived strain which could both cause dise…”
BackgroundPoliovirus Vaccine–Inactivated
Vidor, E. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00047-x · Cited by 93
Serial Recombination during Circulation of Type 1 Wild-Vaccine Recombinant Polioviruses in China
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Kew, O. M., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.10994-11005.2003 · Cited by 88
“By contrast, recombination within the noncapsid region appears to be relatively common (3, 5, 6, 9, 12, 15, 18, 21, 22, 25, 36, 41).”
BackgroundSelf-citationPicornavirus non-structural proteins as targets for new anti-virals with broad activity
Norder, H., Palma, A. M. D., Selisko, B., Costenaro, L., Papageorgiou, N., Arnan, C., Coutard, B., Lantez, V., de Lamballerie, X. N., Baronti, C., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2010.12.007 · Cited by 89
West Nile Virus Infection in Crocodiles
Steinman, A., Banet-Noach, C., Tal, S., Levi, O., Simanov, L., Perk, S., Malkinson, M., & Shpigel, N. Y. (2003) · Emerging infectious diseases · doi:10.3201/eid0907.020816 · Cited by 90
Martín, J., Samoilovich, E., Dunn, G., Lackenby, A., Feldman, E., Heath, A., Svirchevskaya, E., Cooper, G., Yermalovich, M., & Minor, P. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10921-10928.2002 · Cited by 86
“More recently, in 2000 and 2001, two unrelated outbreaks of type 1 poliomyelitis on the island of Hispaniola (Dominican Republic and Haiti) (20) and in the Philippines (1) have been linked to Sabin 1-derived strains.”
BackgroundInfluentialEffect of different vaccination schedules on excretion of oral poliovirus vaccine strains
Laassri, M., Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., & Chumakov, K. (2005) · The Journal of Infectious Diseases · doi:10.1086/498172 · Cited by 85
Kallert, S. M., Darbre, S., Bonilla, W. V., Kreutzfeldt, M., Page, N., Müller, P., Kreuzaler, M., Lu, M., Favre, S., Kreppel, F., et al. (2017) · Nature Communications · doi:10.1038/ncomms15327 · Cited by 88
The Risks, Costs, and Benefits of Possible Future Global Policies for Managing Polioviruses
Thompson, K. M., Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Sutter, R. W., Aylward, R. B., Watkins, M., Gary, H. E., Alexander, J. P., Jafari, H. S., et al. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.122192 · Cited by 81
“Within the past decade, polio outbreaks also occurred from circulating vaccine-derived poliovirus—outbreaks in which OPV viruses regained neurovirulence and greater transmissibility as they circulated in susceptible populations.(2,19) These events provided an even stronger case for coordinated OPV cessation while rais…”
BackgroundSelf-citationVaccination against polio should not be stopped
Chumakov, K., Ehrenfeld, E., Wimmer, E., & Agol, V. I. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1769 · Cited by 85
Muslin, C., Joffret, M., Pelletier, I., Blondel, B., & Delpeyroux, F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005266 · Cited by 86
Impaired Binding of Standard Initiation Factors Mediates Poliovirus Translation Attenuation
Ochs, K., Zeller, A., Saleh, L., Bassili, G., Song, Y., Sonntag, A., & Niepmann, M. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.115-122.2003 · Cited by 90
Lowry, K., Woodman, A., Cook, J., & Evans, D. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004191 · Cited by 89
“a community with low vaccine coverage [27,72,73].”
Pliaka, V., Kyriakopoulou, Z., & Markoulatos, P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.28 · Cited by 85
Chevaliez, S., Szendrôi, A., Caro, V., Balanant, J., Guillot, S., Berencsi, G., & Delpeyroux, F. (2004) · Virology · doi:10.1016/j.virol.2004.04.026 · Cited by 81
A Large Vaccine‐Derived Poliovirus Outbreak on Madura Island—Indonesia, 2005
Estívariz, C. F., Watkins, M. A., Handoko, D., Rusipah, R., Deshpande, J., Rana, B. J., Irawan, E., Widhiastuti, D., Pallansch, M. A., Thapa, A., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/525049 · Cited by 77
“paniola [10].”
BackgroundSelf-citationCertification of polio eradication: process and lessons learned.
Smith, J., Leke, R., Adams, A. I., & Tangermann, R. H. (2004) · Europe PMC (PubMed Central) · Cited by 75
The final stages of the global eradication of poliomyelitis
Grassly, N. C. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0140 · Cited by 80
“This risk remained theoretical until the year 2000, when genetic sequence analysis of poliovirus isolated during an outbreak of poliomyelitis in Haiti and the Dominican Republic found a serotype 1 Sabin origin for the virus [7].”
BackgroundHanley, K. A., Manlucu, L. R., Gilmore, L. E., Blaney, J. E., Hanson, C. T., Murphy, B. R., & Whitehead, S. S. (2003) · Virology · doi:10.1016/s0042-6822(03)00197-1 · Cited by 81
Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis
Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Soresina, A. R., Vivarelli, R., Delpeyroux, F., Martin, J., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.18974-0 · Cited by 73
“Even more worrying is the fact that VAPP outbreaks, reported recently in the Caribbean and the Philippines, have been caused by highly mutated and neurovirulent Sabin-like type 1 polioviruses (Kew et al., 2002; CDC, 2002a).”
BackgroundKorotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., & Agol, V. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12460-12465.2003 · Cited by 73
“Evidence for the circulation of Sabin 1 and Sabin 3 viruses in the population studied here was not so strong but is certainly deserving of attention, the more so since circulation of derivatives of the former in an inadequately vaccinated population has already been reported (4, 17).”
BackgroundSelf-citation
Metadata
- Authors
- Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van der Avoort, H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M., & de Quadros, C.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Caribbean Epidemiology Centre (CAREC) Laboratory, Pan American Health Organization (PAHO), 16-18 Jamaica Boulevard, Federation Park, Port-of-Spain, Trinidad and Tobago.
- World Health Organization Regional Office for the Americas (US)
- Ministry of Health, Avenida San Cristóbal esquina Tiradentes, Santo Domingo, Dominican Republic.
- Ministry of Public Health, Port-au-Prince, Haiti.
- PAHO, Calle Pepillo Salcedo, Plaza de la Salud, Santo Domingo, Dominican Republic.
- PAHO, Number 295 Avenue John Brown, Port-au-Prince, Haiti.
- National Institute of Infectious Diseases (JP)
- Polio Laboratory, National Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 BA, Bilthoven, Netherlands.
- Division of Vaccines and Immunization, PAHO, 525 Twenty-Third Street, N.W., Washington, DC 20037, USA.
- Corresponding author
- Kew, Olen
- ORCID
- Venue
- Science
- Published
- 2002-04-12
- Volume
- 296
- Issue
- 5566
- Pages
- 356-359
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101037145
- Cited by
- 600
- References
- 19
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 20 · 2021: 15 · 2020: 17 · 2019: 17 · 2018: 21 · 2017: 21 · 2016: 26 · 2015: 22 · 2014: 39 · 2013: 26 · 2012: 26
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- poliomyelitis outbreak, vaccine-derived poliovirus, poliovirus type 1, oral polio vaccine, Hispaniola, Dominican Republic, Haiti, unvaccinated children, low vaccination coverage, paralytic poliomyelitis, wild poliovirus
- MeSH terms
- Adolescent, Animals, Capsid, Child, Child, Preschool, Disease Outbreaks, Dominican Republic, Female, Genes, Viral, Haiti, Humans, Infant, Male, Molecular Sequence Data, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Recombination, Genetic, Vaccination, Virulence, Point Mutation, Immunization Programs, Poliovirus, 5' Untranslated Regions, Capsid Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.